<![CDATA[A health ministry panel has approved healthcare coverage for Sumitomo Pharma's Parkinson's disease treatment Amchepry, making it the world's first commercialized medical product derived from iPS cells.]]>A health ministry panel has approved healthcare coverage for Sumitomo Pharma's Parkinson's disease treatment Amchepry, making it the world's first commercialized medical product derived from iPS cells. https://www.japantimes.co.jp/news/2026/05/13/japan/science-health/ips-parkinsons-disease/?utm_medium=Social&utm_source=mastodon

]]>https://postcall.pub/topic/e341fef3-558c-468c-b047-2cc51f37a491/a-health-ministry-panel-has-approved-healthcare-coverage-for-sumitomo-pharma-s-parkinson-s-disease-treatment-amchepry-making-it-the-world-s-first-commercialized-medical-product-derived-from-ips-cells.RSS for NodeMon, 25 May 2026 01:30:25 GMTWed, 13 May 2026 21:38:01 GMT60